ECB's Wunsch: We must accept that our ability to fix inflation at exactly 2% is limited

ULS's 18.3% return is strong, but declining margins & ROIC at 40.6x P/E signal caution.

Skydance vows 30 films/yr post-$110B Warner Bros deal, but theater owners fear fewer releases.

IBP's 11.2% gain beats S&P 500. Strong EPS growth but revenue may stall. Trades at 25.8x P/E.

JNJ, ABT, BDX: Dividend Kings with recurring revenue offer defensive healthcare plays, outperforming in downturns despite litigation risks.

YORW drops 5% on share dilution & discount pricing. Now at 52-week low, but offers potential value.

MGNI drops 26.9% to $13.38, but boasts 26.4% sales growth & 27.1% FCF margin. Trades at 11.8x forward P/E.

Fintech growth shines (35%+ revenue), but watch profits & valuation. PYPL trades 84% off peak!